Data from FDA-advised study demonstrates Lumee™ Oxygen tissue monitoring is a safe and effective long-term method in PAD patients and will support potential FDA submission; strongly correlates with ...

Although a new study of hyperbaric oxygen therapy in JAMA Oncology has been " anxiously awaited" by breast radiation oncologists, the trial does not provide the smoking gun evidence that would justify ...